Clinical Evaluation of Traditional Chinese Medicine-Jiawei Taohong Siwu Decoction in Treating Severe Non-proliferative DRP

Phase 1

Recruiting

• Conditions: Diabetic retinopathy

• Registration Number: ITMCTR2100004282
• Lead Sponsor: Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

(1) All cases were diagnosed as type 2 diabetes patients by the Department of Endocrinology. Women of childbearing age undergo HCG testing.
(2) There is no restriction on gender, and the age range is 20 to 70 years old.
(3) The changes in the fundus accord with the international clinical classification of DRP as mild, moderate and severe non-proliferative DRP (without DME).
(4) The TCM syndrome type belongs to the type of deficiency of both qi and yin and blood stasis blocking the collaterals.

Exclusion Criteria

(1) Hyperglycemia is not effectively controlled (fasting blood glucose >= 19.0mmol/L).
(2) Cases of other ophthalmological diseases that affect vision or effect observation, such as glaucoma, uveitis, severe cataract, vitreous hemorrhage, fundus vein occlusion, optic neuritis, retinal detachment, etc.
(3) Patients with serious diseases such as other organs (such as heart, brain, liver), or mental illness.
(4) Diabetic nephropathy and renal failure (uremia stage).
(5) Women who are pregnant, preparing to become pregnant or breastfeeding.
(6) Observers who do not cooperate and interrupt treatment.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Correct vision;Naked eyesight;Linear density of superficial retinal vessels;Superficial retinal blood vessel perfusion density;intraocular pressure;Macular foveal avascular area;